Edition:
United States

MiMedx Group Inc (MDXG.OQ)

MDXG.OQ on NASDAQ Stock Exchange Capital Market

11.82USD
17 Nov 2017
Change (% chg)

$0.46 (+4.05%)
Prev Close
$11.36
Open
$11.55
Day's High
$11.93
Day's Low
$11.33
Volume
555,832
Avg. Vol
636,664
52-wk High
$17.47
52-wk Low
$7.64

Select another date:

Fri, Nov 17 2017

BRIEF-MiMedx Group sees FY 2017 revenue $320.6 million to $321.6 million

* MiMedx Group Inc - ‍reiterates Q4 and full year 2017 guidance​

BRIEF-MiMedx announces Q3 2017 results

* MiMedx announces record results for third quarter of 2017 and raises full year revenue guidance

BRIEF-Mimedx Group Inc preliminary Q3 revenue $84.6 million

* Announces third quarter revenues of $84.6 million exceeds guidance by more than 5 percent

BRIEF-MiMedx board authorizes $10 mln increase to share repurchase program

* MiMedx board of directors authorizes $10 million increase to the company's share repurchase program

BRIEF-MIMEDX GROUP REAFFIRMS REVENUE EXPECTATIONS FOR Q3

* DR. GLORIA MATTHEWS JOINS MIMEDX AS ITS SENIOR VICE PRESIDENT OF RESEARCH AND DEVELOPMENT

BRIEF-Court sets trial date for MiMedx patent infringement lawsuit

* Court sets the trial date for MiMedx patent infringement lawsuit against MTF, Medline and Liventa

BRIEF-MiMedx agrees to lawsuit settlement with terminated employee

* MiMedx agrees to lawsuit settlement with terminated employee

BRIEF-MiMedx provides information on its interaction with the SEC

* MiMedx provides information on its interaction with the SEC

BRIEF-Mimedx files with FDA to initiate co's investigational new drug Phase 2 clinical trial for Osteoarthritis of Knee

* Mimedx files with the FDA to initiate the company's investigational new drug phase 2 clinical trial for Osteoarthritis of the knee

BRIEF-MiMedx Group updates on co's patent infringement lawsuit

* Company prevailed in its patent infringement lawsuit against Musculoskeletal Transplant Foundation Inc​

Select another date: